BeclometasoneFormoterol_MometasoneFormoterolQualityChecker
Beclometasone/Formoterol & Mometasone/Formoterol Quality Checker
ℹ️ Utility checks critical parameters of ICS/LABA combination inhalers:
• Supported types: BEC-FOR (Beclometasone), MOM-FOR (Mometasone)
• Steroid Content: Within product specification
• Formoterol Content: Within therapeutic range
• Fine Particle Fraction (FPF): ≥15%
• Dose Uniformity: deviation ≤15%
• Moisture Content: ≤1.0%
• Impurities: ≤1.5%
• Valve Leak Rate: ≤0.5 mL/min
• Actuator Force: 15–25 N
⚠️ CRITICAL: Low fine particle fraction reduces corticosteroid delivery to peripheral lungs.
Usage:
BeclometasoneFormoterol_MometasoneFormoterolQualityChecker.exe → demo mode
BeclometasoneFormoterol_MometasoneFormoterolQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,ProductType,SteroidAssayMcgPerDose,FormoterolAssayMcgPerDose,FineParticleFractionPercent,DeliveredDoseUniformityDeviation,MoistureContentPercent,ImpuritiesTotalPercent,ValveLeakRateMlPerMin,ActuatorForceNewton
Example:
BEC-FOR-2026-001,BEC-FOR,100.0,6.0,22.0,7.5,0.3,0.6,0.1,18.0
— WHY IS THIS NEEDED?
Combinations of Inhaled Corticosteroids (ICS) and Long-Acting Beta-Agonists (LABA) are standard therapy for asthma and COPD:
• Beclometasone dipropionate — classic ICS, often in "extrafine" form for better penetration
• Mometasone furoate — modern ICS with high safety profile
• Formoterol — fast-onset and long-acting bronchodilator
• Inhalation form requires strict control of aerodynamic properties
⚠️ CRITICAL:
• Component content must match declared dose for anti-inflammatory and bronchodilatory effect
• Fine Particle Fraction (FPF) determines the fraction of drug reaching small airways and alveoli
• Dose uniformity is critical for therapy stability
• Moisture affects powder particle aggregation and metering valve operation
• System tightness prevents drug loss
Key features:
• Support for two different steroid components (Beclometasone and Mometasone)
• Control of aerodynamic parameters (FPF), critical for ICS
• Assessment of mechanical device characteristics (valve, actuator)
• Stability check of composition (moisture, impurities)
Critical parameters:
• Steroid Assay: Product Specific (e.g., 85-115% of label claim)
• Formoterol Assay: Therapeutic Range
• Fine Particle Fraction: ≥15%
• Dose Uniformity Deviation: ≤15%
• Moisture Content: ≤1.0%
• Total Impurities: ≤1.5%
• Valve Leak Rate: ≤0.5 mL/min
• Actuator Force: 15–25 N
💡 Usage tips:
1. Content determined by HPLC after extraction from inhaler
2. Fine Particle Fraction measured using cascade impactor (USP <601>)
3. Beclometasone is characterized by high proportion of fine particles (extrafine technology)
4. Moisture controlled by Karl Fischer method
5. Tightness checked on specialized leak testers
⚠️ Note: Beclometasone dipropionate is often formulated as a suspension in HFA using ethanol as co-solvent, requiring special control of moisture and tightness. Mometasone furoate is also sensitive to environmental conditions. Proper metering valve operation ensures accuracy of each individual dose.
input.csv
BatchNumber,ProductType,SteroidAssayMcgPerDose,FormoterolAssayMcgPerDose,FineParticleFractionPercent,DeliveredDoseUniformityDeviation,MoistureContentPercent,ImpuritiesTotalPercent,ValveLeakRateMlPerMin,ActuatorForceNewton BEC-FOR-2026-001,BEC-FOR,100.0,6.0,22.0,7.5,0.3,0.6,0.1,18.0 MOM-FOR-2026-001,MOM-FOR,100.0,5.0,18.0,8.0,0.4,0.7,0.2,19.5
BeclometasoneFormoterol_MometasoneFormoterolQualityChecker — Documentation
input.csv and *.description.txt. Package folder: Global/API coverage extension.Utility description
Beclometasone/Formoterol & Mometasone/Formoterol Quality Checker — ICS/LABA Combination Inhaler Quality Control
ℹ️ Utility checks critical parameters of ICS/LABA combination inhalers:
• Supported types: BEC-FOR (Beclometasone), MOM-FOR (Mometasone)
• Steroid Content: Within product specification
• Formoterol Content: Within therapeutic range
• Fine Particle Fraction (FPF): ≥15%
• Dose Uniformity: deviation ≤15%
• Moisture Content: ≤1.0%
• Impurities: ≤1.5%
• Valve Leak Rate: ≤0.5 mL/min
• Actuator Force: 15–25 N
⚠️ CRITICAL: Low fine particle fraction reduces corticosteroid delivery to peripheral lungs.
Usage:
BeclometasoneFormoterol_MometasoneFormoterolQualityChecker.exe → demo mode
BeclometasoneFormoterol_MometasoneFormoterolQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,ProductType,SteroidAssayMcgPerDose,FormoterolAssayMcgPerDose,FineParticleFractionPercent,DeliveredDoseUniformityDeviation,MoistureContentPercent,ImpuritiesTotalPercent,ValveLeakRateMlPerMin,ActuatorForceNewton
Example:
BEC-FOR-2026-001,BEC-FOR,100.0,6.0,22.0,7.5,0.3,0.6,0.1,18.0
— WHY IS THIS NEEDED?
Combinations of Inhaled Corticosteroids (ICS) and Long-Acting Beta-Agonists (LABA) are standard therapy for asthma and COPD:
• Beclometasone dipropionate — classic ICS, often in "extrafine" form for better penetration
• Mometasone furoate — modern ICS with high safety profile
• Formoterol — fast-onset and long-acting bronchodilator
• Inhalation form requires strict control of aerodynamic properties
⚠️ CRITICAL:
• Component content must match declared dose for anti-inflammatory and bronchodilatory effect
• Fine Particle Fraction (FPF) determines the fraction of drug reaching small airways and alveoli
• Dose uniformity is critical for therapy stability
• Moisture affects powder particle aggregation and metering valve operation
• System tightness prevents drug loss
Key features:
• Support for two different steroid components (Beclometasone and Mometasone)
• Control of aerodynamic parameters (FPF), critical for ICS
• Assessment of mechanical device characteristics (valve, actuator)
• Stability check of composition (moisture, impurities)
Critical parameters:
• Steroid Assay: Product Specific (e.g., 85-115% of label claim)
• Formoterol Assay: Therapeutic Range
• Fine Particle Fraction: ≥15%
• Dose Uniformity Deviation: ≤15%
• Moisture Content: ≤1.0%
• Total Impurities: ≤1.5%
• Valve Leak Rate: ≤0.5 mL/min
• Actuator Force: 15–25 N
💡 Usage tips:
1. Content determined by HPLC after extraction from inhaler
2. Fine Particle Fraction measured using cascade impactor (USP <601>)
3. Beclometasone is characterized by high proportion of fine particles (extrafine technology)
4. Moisture controlled by Karl Fischer method
5. Tightness checked on specialized leak testers
⚠️ Note: Beclometasone dipropionate is often formulated as a suspension in HFA using ethanol as co-solvent, requiring special control of moisture and tightness. Mometasone furoate is also sensitive to environmental conditions. Proper metering valve operation ensures accuracy of each individual dose.URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of BeclometasoneFormoterol_MometasoneFormoterolQualityChecker for Beclometasone/Formoterol & Mometasone/Formoterol Quality Checker.
Portal packages
Global/API coverage extension, LabEx QC laboratory utilities, Lumex QC instrument utilities, Medical Gases / inhaler-adjacent QC Suite, World API/FDC extension
AsthmaCOPDCSV→JSONFDCInhalerMissingAPIQCRespiratoryURS & FSP2Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of ICS/LABA combination inhalers:
- • Steroid Content: Within product specification
- • Formoterol Content: Within therapeutic range
- • Fine Particle Fraction (FPF): ≥15%
- • Dose Uniformity: deviation ≤15%
- • Moisture Content: ≤1.0%
- • Impurities: ≤1.5%
- • Valve Leak Rate: ≤0.5 mL/min
- ⚠️ CRITICAL: Low fine particle fraction reduces corticosteroid delivery to peripheral lungs.
- BatchNumber,ProductType,SteroidAssayMcgPerDose,FormoterolAssayMcgPerDose,FineParticleFractionPercent,DeliveredDoseUniformityDeviation,MoistureContentPercent,ImpuritiesTotalPercent,ValveLeakRateMlPerMin,ActuatorForceNewton
- ⚠️ CRITICAL:
- • Component content must match declared dose for anti-inflammatory and bronchodilatory effect
- • Dose uniformity is critical for therapy stability
- • Control of aerodynamic parameters (FPF), critical for ICS
- • Stability check of composition (moisture, impurities)
- Critical parameters:
- • Steroid Assay: Product Specific (e.g., 85-115% of label claim)
- • Formoterol Assay: Therapeutic Range
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file for Beclometasone/Formoterol & Mometasone/Formoterol Quality Checker with headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions. | High | Identical input data, rule version and configuration produce reproducible results. |
| URS-003 | The utility shall validate mandatory fields, data types, ranges, units and domain plausibility. | High | Schema, conversion and range errors are explicitly reported. |
| URS-004 | The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs. | High | Each check has PASS/WARNING/FAIL and a clear message. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall preserve traceability between batch/sample, input file, applied rules and final status. | High | Output contains identifiers, checked parameters and audit metadata. |
| URS-007 | The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors. | Medium | URS, FS, input/output contract and test scenarios are supplied with the utility. |
| URS-008 | The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision. | Medium | Documentation states change control and limit-verification expectations. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string / controlled vocabulary | BEC-FOR-2026-001 | Batch or lot identifier used for traceability. |
| 2 | ProductType | string / controlled vocabulary | BEC-FOR | Product or dosage-form name under evaluation. |
| 3 | SteroidAssayMcgPerDose | decimal | 100.0 | Quantitative content/potency; critical release parameter. |
| 4 | FormoterolAssayMcgPerDose | decimal | 6.0 | Quantitative content/potency; critical release parameter. |
| 5 | FineParticleFractionPercent | decimal | 22.0 | Size/particle attribute; physicochemical quality parameter. |
| 6 | DeliveredDoseUniformityDeviation | decimal | 7.5 | Controlled input parameter for deterministic QC rules. |
| 7 | MoistureContentPercent | decimal | 0.3 | Quantitative content/potency; critical release parameter. |
| 8 | ImpuritiesTotalPercent | decimal | 0.6 | Impurity/related-substance parameter; purity and degradation control. |
| 9 | ValveLeakRateMlPerMin | decimal | 0.1 | Controlled input parameter for deterministic QC rules. |
| 10 | ActuatorForceNewton | decimal | 18.0 | Controlled input parameter for deterministic QC rules. |
BatchNumber,ProductType,SteroidAssayMcgPerDose,FormoterolAssayMcgPerDose,FineParticleFractionPercent,DeliveredDoseUniformityDeviation,MoistureContentPercent,ImpuritiesTotalPercent,ValveLeakRateMlPerMin,ActuatorForceNewton BEC-FOR-2026-001,BEC-FOR,100.0,6.0,22.0,7.5,0.3,0.6,0.1,18.0 MOM-FOR-2026-001,MOM-FOR,100.0,5.0,18.0,8.0,0.4,0.7,0.2,19.5
Input validation rules
| ID | Field | Rule | Criticality |
|---|---|---|---|
| VR-001 | BatchNumber | The field shall match an approved dictionary or accepted string representation. | High |
| VR-002 | ProductType | The field shall match an approved dictionary or accepted string representation. | High |
| VR-003 | SteroidAssayMcgPerDose | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-004 | FormoterolAssayMcgPerDose | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-005 | FineParticleFractionPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-006 | DeliveredDoseUniformityDeviation | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-007 | MoistureContentPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-008 | ImpuritiesTotalPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-009 | ValveLeakRateMlPerMin | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-010 | ActuatorForceNewton | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CLI execution | Support execution modes: demo mode without arguments and production mode input.csv output.json. |
| FS-002 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns. |
| FS-003 | Schema validation | Check mandatory fields, column count, unknown key fields and empty mandatory values. |
| FS-004 | Type conversion | Convert numeric, flag and text values; invalid format is recorded as a row-level error. |
| FS-005 | Domain rule engine | Apply rules for Beclometasone/Formoterol & Mometasone/Formoterol Quality Checker, including critical limits from the description and approved specification. |
| FS-006 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-007 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-008 | Audit support | Keep result structure suitable for review, deviation investigation and calculation reproduction. |
| FS-009 | Integration contract | Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review. |
| FS-010 | Fallback mapping | If the combined utility is not deployed, use component checks: formoterol-quality-checker, mometasone-quality-checker, beclometasone-quality-checker plus generic Lumex/LabEx checks. |
| FS-011 | Error handling | Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format. |
Example output.json
{
"utilityId": "beclometasone-formoterol-mometasone-formoterol-quality-checker",
"utilityFolder": "BeclometasoneFormoterol_MometasoneFormoterolQualityChecker",
"package": "Global/API coverage extension",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"processedAtUtc": "2026-07-02T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "BEC-FOR-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-001"
},
{
"parameter": "ProductType",
"value": "BEC-FOR",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-002"
},
{
"parameter": "SteroidAssayMcgPerDose",
"value": "100.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-003"
},
{
"parameter": "FormoterolAssayMcgPerDose",
"value": "6.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-004"
},
{
"parameter": "FineParticleFractionPercent",
"value": "22.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-005"
},
{
"parameter": "DeliveredDoseUniformityDeviation",
"value": "7.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-006"
},
{
"parameter": "MoistureContentPercent",
"value": "0.3",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-007"
},
{
"parameter": "ImpuritiesTotalPercent",
"value": "0.6",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-008"
},
{
"parameter": "ValveLeakRateMlPerMin",
"value": "0.1",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-009"
},
{
"parameter": "ActuatorForceNewton",
"value": "18.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-010"
}
],
"criticalFindings": [],
"warnings": [],
"audit": {
"inputHash": "sha256:<calculated at runtime>",
"rulesVersion": "<utility executable version>",
"documentation": "BeclometasoneFormoterol_MometasoneFormoterolQualityChecker.documentation.html"
}
}
Traceability matrix
| URS | FS | Test | Evidence |
|---|---|---|---|
| URS-001 | FS-001, FS-002 | OQ-001 | Verify execution and import of valid input.csv. |
| URS-002 | FS-005, FS-006 | OQ-004 | Repeat the same dataset and compare output.json. |
| URS-003 | FS-003, FS-004, FS-011 | OQ-002, OQ-003 | Verify missing columns and invalid types. |
| URS-004 | FS-005, FS-006 | OQ-004, PQ-001 | Verify critical deviations on real/boundary data. |
| URS-005 | FS-007, FS-009 | OQ-005 | Verify JSON schema and downstream-system suitability. |
| URS-006 | FS-008 | OQ-006 | Verify identifiers and audit metadata. |
| URS-007 | FS-008, FS-011 | IQ-001, OQ-007 | Verify documentation completeness and control evidence. |
| URS-008 | FS-005, FS-008, FS-010 | PQ-002 | Verify review workflow and no replacement of QA decision. |
IQ/OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| IQ-001 | Verify executable, input.csv, documentation and checksum availability. | Delivery set is complete; version is recorded. |
| OQ-001 | Valid sample row from input.csv. | PASS or acceptable WARNING according to rules. |
| OQ-002 | Remove a mandatory CSV column. | Schema error or FAIL with missing-column reference. |
| OQ-003 | Place a non-numeric value into a numeric field. | Type-conversion error with row/field reference. |
| OQ-004 | Set a critical parameter outside the limit. | FAIL and critical finding. |
| OQ-005 | Verify output.json structure. | All mandatory sections are present and JSON is valid. |
| OQ-006 | Verify batch/sample traceability. | Input and result identifiers match. |
| OQ-007 | Verify fallback/decomposition for combined APIs. | Component checks are explicitly documented. |
| PQ-001 | Verify 3–5 real user batches/samples. | Result is confirmed by QC/QA review. |
| PQ-002 | Verify deviation workflow and manual QA decision. | Utility supports review but does not replace approved decision. |
QA/QC and change control
- Do not rename columns without updating validator, documentation and test set.
- Retain input.csv, output.json, executable version and checksum.
- Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
- For combination products, document whether the specialized FDC utility or fallback component checks were used.
- The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.
Included in packages
Global API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenMedical Gases QC Suite
Quality-control package for medical and pharmaceutical gases: oxygen, nitrogen, carbon dioxide, nitrous oxide, helium and mixtures.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open